Study identifier:BY9010/M1-208
ClinicalTrials.gov identifier:NCT00163371
EudraCT identifier:N/A
CTIS identifier:N/A
Effect of Ciclesonide (320 mcg/day) vs Fluticasone Propionate (375 mcg/day) vs. Placebo on Short-term Linear Growth Rate and HPA-axis Function in Prepubertal Children with Mild Asthma
asthma
Phase 3
No
Ciclesonide
All
28
Interventional
6 Years - 12 Years
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verified 01 Oct 2016 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|